Connection

David Taber to Antibodies, Blocking

Back to Details
This is a "connection" page, showing publications David Taber has written about Antibodies, Blocking.
David Taber
Connection Strength
0.028
Antibodies, Blocking
  1. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.